View in EDS

Discovery of Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Cotransporter NaPi2a (SLC34A1).

Saved in:
Bibliographic Details
Title: Discovery of Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Cotransporter NaPi2a (SLC34A1).
Authors: Filipski KJ; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Sammons MF; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Bhattacharya SK; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Panteleev J; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Brown JA; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Loria PM; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Boehm M; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Smith AC; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Shavnya A; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Conn EL; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Song K; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Weng Y; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Facemire C; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Jüppner H; Endocrine Unit and Pediatric Nephrology Unit, Thier 10, Massachusetts General Hospital and Harvard Medical School, 50 Blossom Street, Boston, Massachusetts 02114, United States., Clerin V; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States.
Source: ACS medicinal chemistry letters [ACS Med Chem Lett] 2018 Apr 12; Vol. 9 (5), pp. 440-445. Date of Electronic Publication: 2018 Apr 12 (Print Publication: 2018).
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101521073 Publication Model: eCollection Cited Medium: Print ISSN: 1948-5875 (Print) Linking ISSN: 19485875 NLM ISO Abbreviation: ACS Med Chem Lett Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1948-5875
DOI:10.1021/acsmedchemlett.8b00013